Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Steve H. who wrote (3317)	4/5/1998 10:54:00 PM
From: Brander	Read Replies (1) \| Respond to of 7041

Steve, that is a point certainly worth considering. The job of the drug reps is to sell their companies drugs, and I certainly take that into consideration when listening to them. Currently, the Pfizer reps are not going to have to work very hard, as the demand for Viagra is amazing. The information that the Pfizer rep shared with me was that they considered Vasomax to be their main competition down the road. She let me read part of it, and it was there, clearly stated. It is possible, I guess, that it could be a ploy by Pfizer to keep their reps energized, since they really don't have anything to fight against currently. Brad